Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >INF 195
INF 195
  • INF 195

INF 195 NEW

Price $33 $68 $107
Package 10mg 25mg 50mg
Min. Order:
Supply Ability: 10g
Update Time: 2025-11-10

Product Details

Product Name: INF 195 CAS No.: 1211379-56-4
Purity: 99.78% Supply Ability: 10g
Release date: 2025/11/10

Product Introduction

Bioactivity

NameINF 195
DescriptionINF 195 is an inflammasome NLRP3 inhibitor that inhibits NLRP3-driven macrophage pyroptosis and IL-1β release. INF 195 reduces isoproterenol-induced hypertrophy in H9c2 rat myoblasts and can be used to study myocardial ischemia and myocardial infarction.
In vitroINF 195 (0.1-100 μM, 72 hours) was able to inhibit macrophage pyroptosis and IL-1β release driven by NLRP3. At lower doses (5-10 μM, 10 min), INF 195 was able to reduce the infarct zone in isolated mouse hearts and effectively prevented myocardial ischemia/reperfusion injury.INF 195 (10 μM), as an ethyl ester precursor of the active metabolite 3-(3-(2-chlorophenyl)propanoyl)piperidine-1-carboxylic acid, was able to penetrate into H9c2 cardiomyoblasts, and hydrolyzed intracellularly to this active form. [1]
Storagestore at low temperature | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility InformationDMSO : 150 mg/mL (463.23 mM), Sonication is recommended.
KeywordsNLRP3
Inhibitors RelatedStavudine | Disulfiram | Sodium Thiocyanate | 10-Hydroxydecanoic Acid | Inosine pranobex | Ethyl palmitate | Theophylline monohydrate | Balsalazide disodium dihydrate | 1,8-Cineole | NLRP3-IN-2 | Prednisone acetate | Lornoxicam
Related Compound LibrariesBioactive Compound Library | Anti-Alzheimer's Disease Compound Library | Anti-Ovarian Cancer Compound Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Anti-Cancer Compound Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/1g
Wuhan Circle Star Chem-medical Technology Co.,Ltd
2025-01-07
$0.00/1KG
VIP4Y
Henan Aochuang Chemical Co.,Ltd.
2022-09-29
$1.10/1g
VIP5Y
Dideu Industries Group Limited
2021-08-18

TargetMol Chemicals Inc.

6YR United StatesUnited States
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY